| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 19 |
| 1 | NIVOLUMAB | 10 |
| 2 | DURVALUMAB | 6 |
| 3 | LEVOTHYROXINE SODIUM ANHYDROUS | 6 |
| 4 | SILDENAFIL CITRATE | 6 |
| 5 | PEMBROLIZUMAB | 5 |
| 6 | ACETAMINOPHEN | 4 |
| 7 | ALEMTUZUMAB | 4 |
| 8 | SILDENAFIL | 4 |
| 9 | CELECOXIB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE | 3 | 0.0020 |
| 1 | DANTROLENE SODIUM | 1 | 0.0009 |
| 2 | GALANTAMINE HYDROBROMIDE | 1 | 0.0006 |
| 3 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 1 | 0.0004 |
| 4 | DURVALUMAB | 6 | 0.0003 |
| 5 | METHIMAZOLE | 2 | 0.0003 |
| 6 | ALEMTUZUMAB | 4 | 0.0002 |
| 7 | CALCIUM ACETATE | 1 | 0.0002 |
| 8 | TRANEXAMIC ACID | 1 | 0.0001 |
| 9 | NIVOLUMAB | 10 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 6 | 0.0003 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 2 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 3 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 10 | 0.0001 |
| 5 | Progesterone [EPC] | 1 | 0.0000 |
| 6 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Estrogen [EPC] | 5 | 0.0000 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 2 | 0.0000 |
| 9 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |